Searching: http://spark.kufu.no/fhir/_snapshot?id=e205dbab-b74d-45ce-a412-de2544820d59&start=0
From RowNum: 0
id: e205dbab-b74d-45ce-a412-de2544820d59 (excluded)
start: 0
First Link: http://spark.kufu.no/fhir/_snapshot?id=e205dbab-b74d-45ce-a412-de2544820d59&start=0
Last Link: http://spark.kufu.no/fhir/_snapshot?id=e205dbab-b74d-45ce-a412-de2544820d59&start=0
Type: Searchset, 1 of 1
MedicinalProductIndication/example/_history/1 Modified: 5/28/2019 2:47:38 PM +02:00

Generated Narrative with Details

id: example

diseaseSymptomProcedure: Prevention of venous thromboembolic events (VTE) in adult patients who have undergone elective hip\nor knee replacement surgery.\nPrevention of stroke and systemic embolism in adult patients with non-valvular atrial fibrillation\n(NVAF), with one or more risk factors, such as prior stroke or transient ischaemic attack (TIA); age\n≥ 75 years; hypertension; diabetes mellitus; symptomatic heart failure (NYHA Class ≥ II).\nTreatment of deep vein thrombosis (DVT) and pulmonary embolism (PE), and prevention of recurrent\nDVT and PE in adults (see section 4.4 for haemodynamically unstable PE patients). (Details : {http://ema.europa.eu/example/indicationasdisease-symptom-procedure code 'Venousthromboembolismprophylaxis' = 'Venousthromboembolismprophylaxis)

comorbidity: Hipsurgery (Details : {http://ema.europa.eu/example/comorbidity code 'Hipsurgery' = 'Hipsurgery)

intendedEffect: PRYLX (Details : {http://ema.europa.eu/example/intendedeffect code 'PRYLX' = 'PRYLX)

population: